Showing results (1521-1530 of 2,128) with videos related to

Sort By:
Pageof 213
Rheumatology International|July 28, 2011
Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experienceLun-Fang Xie, Pei-Ling Chen, Hai-Feng Pan, et al.
Annals of Medicine|September 23, 2021
Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studiesXian-Bao Li, Nv-Wei Cao, Xiu-Jie Chu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 22, 2020
Optimized mouse model of embolic MCAO: From cerebral blood flow to neurological outcomesRongrong Wang, Hailian Wang, Yaan Liu, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
First Evidence of Function for Schistosoma japonicumriok-1 and RIOK-1Mudassar N Mughal, Qing Ye, Lu Zhao, et al.
Rheumatology (Oxford, England)|February 6, 2014
Associations between vitamin D receptor gene polymorphisms and osteoarthritis: an updated meta-analysisZhao-Hua Zhu, Xing-zhong Jin, Weiya Zhang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 1, 2005
[Study on the clinical epidemiology of systemic lupus erythematosus among 1433 cases]Yong-qing Zhang, Dong-qing Ye, Xiang-pei Li, et al.
Genetic Testing and Molecular Biomarkers|August 27, 2013
Associations of interleukin-4 receptor gene polymorphisms (Q551R, I50V) with rheumatoid arthritis: evidence from a meta-analysisHui Peng, Wei Wang, Mo Zhou, et al.
Clinical Rheumatology|March 10, 2018
Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patientsShu-Zhen Xu, Yan Liang, Xiang-Pei Li, et al.
Expert Opinion on Therapeutic Targets|May 30, 2017
Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseasesShi-Yang Guan, Rui-Xue Leng, Jin-Hui Tao, et al.
International Journal of Clinical and Experimental Medicine|March 19, 2015
Short-term effect and adverse events of adalimumab versus placebo in inducing remission for moderate-to-severe ulcerative colitis: a meta-analysisZheng Yang, Xiao-Qing Ye, Yu-Zhen Zhu, et al.
Pageof 213